Peyronie's Disease

PCa Surgery Patients Largely Unaware of Sexual Complications

PCa Surgery Patients Largely Unaware of Sexual Complications

By

Many men are unaware of erectile function recovery time and problems with ejaculation.

Few Urologists Treat Peyronie's Disease

Few Urologists Treat Peyronie's Disease

By

Urology subspeciality andrologists perform disproportionately higher numbers of procedures.

Yachia Corporoplasty Offers Long-Term Peyronie's Relief

Yachia Corporoplasty Offers Long-Term Peyronie's Relief

By

Single-institution study finds most patients satisfied with the results and would have the surgery again.

CCH Injection Interval Flexible in Peyronie's Patients

CCH Injection Interval Flexible in Peyronie's Patients

By

Allowing 1, 2, or 3 or more days between the first and second injection of collagenase clostridium histolyticum does not impact efficacy.

Younger Men Less Satisfied with Peyronie's Disease Treatment

Younger Men Less Satisfied with Peyronie's Disease Treatment

By

Perceived outcomes of patients aged 29 years or younger are different from those of patients in other age groups, study finds.

Penile Traction Does Not Interfere with IFN Therapy for PD

Penile Traction Does Not Interfere with IFN Therapy for PD

By

Study reveals no significant impact on changes in penile curvature or length.

PIG-Related Sensory Loss Rare Beyond 1 Year

PIG-Related Sensory Loss Rare Beyond 1 Year

By

Loss of penile sensation after plaque incision and grafting surgery for Peyonie's disease declines over time.

Nonsurgical Peyronie's Treatments Compared

Nonsurgical Peyronie's Treatments Compared

By

In a study of rats, penile traction had the edge for correcting curvature, but a vacuum erectile device was better for preserving erectile function.

Novel Peyronie's Disease Treatment Shows Efficacy

Novel Peyronie's Disease Treatment Shows Efficacy

By

Penile traction therapy reduced curvature and significantly improved erectile function and hardness.

FDA Approves Peyronie's Disease Drug

FDA Approves Peyronie's Disease Drug

By

It is the first medication approved by the agency for treating this erectile problem.

Experimental Agent Shows Promise for Peyronie's Disease

By

Phase 3 studies assessing XIAFLEX show this agent may significantly improve quality of life.

FDA Approves New Drug for Peyronie's Disease

FDA Approves New Drug for Peyronie's Disease

Collagenase clostridium histolyticum (Xioflex) is first non-surgical treatment to get FDA approval

Peyronie's Disease Treatment Promising

By By

Collagenase injections can decrease penile curvature in men with Peyronie's disease (PD).

Peyronie's Disease Treatment Promising

By

Collagenase injections decrease penile curvature and eases symptom bother, data show.

Calcified Peyronie's Disease Plaques May Predict Surgery

By

Men with severe calcified Peyronie's disease (PD) plaques are more likely to progress to surgical treatment than men with non-calcified plaques.

Drug Found to Benefit Men With Peyronie's Disease

By

Pentoxifylline sustained-release (PTX-SR) is moderately effective reducing penile curvature and plaque volume in men suffering from early Peyronie's disease, researchers concluded.

Shock Waves Relieve Peyronie's Pain

By

Extracorporeal shock wave therapy prevented increases in plaque size and curvature versus placebo.

Buccal Mucosa Grafting Effective for Peyronie's Disease

By

Plaque incision and grafting with buccal mucosa may be a safe and effective treatment option for men with Peyronie's disease (PD).

Sign Up for Free e-newsletters